File Download

There are no files associated with this item.

  • Find it @ UNIST can give you direct access to the published full text of this article. (UNISTARs only)
Related Researcher

조윤경

Cho, Yoon-Kyoung
FRUITS Lab.
Read More

Views & Downloads

Detailed Information

Cited time in webofscience Cited time in scopus
Metadata Downloads

Full metadata record

DC Field Value Language
dc.citation.number 16 -
dc.citation.startPage 2409353 -
dc.citation.title SMALL -
dc.citation.volume 22 -
dc.contributor.author Clarissa, Elizabeth Maria -
dc.contributor.author Karmacharya, Mamata -
dc.contributor.author Choi, Hyunmin -
dc.contributor.author Kumar, Sumit -
dc.contributor.author Cho, Yoon-Kyoung -
dc.date.accessioned 2025-02-24T09:05:07Z -
dc.date.available 2025-02-24T09:05:07Z -
dc.date.created 2025-02-18 -
dc.date.issued 2026-03 -
dc.description.abstract The advent of Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)-based genome editing technologies has opened up groundbreaking possibilities for treating a wide spectrum of genetic disorders and diseases. However, the success of these technologies relies heavily on the development of efficient and safe delivery systems. Among the most promising approaches are natural and synthetic nanocarrier-mediated delivery systems, including viral vectors, extracellular vesicles (EVs), engineered cellular membrane particles, liposomes, and various nanoparticles. These carriers enhance the efficacy of the CRISPR system by providing a unique combination of efficiency, specificity, and reduced immunogenicity. Synthetic carriers such as liposomes and nanoparticles facilitate CRISPR delivery with high reproducibility and customizable functions. Viral vectors, renowned for their high transduction efficiency and broad tropism, serve as powerful vehicles for delivering CRISPR components to various cell types. EVs, as natural carriers of RNA and proteins, offer a stealth mechanism to evade immune detection, allowing for the targeted delivery of genome editors with minimal off-target effects. Engineered cellular membrane particles further improve delivery by simulating the cellular environment, enhancing uptake, and minimizing immune response. This review explores the innovative integration of CRISPR genome editors with various nanocarrier systems, focusing on recent advancements, applications, and future directions in therapeutic genome editing. -
dc.identifier.bibliographicCitation SMALL, v.22, no.16, pp.2409353 -
dc.identifier.doi 10.1002/smll.202409353 -
dc.identifier.issn 1613-6810 -
dc.identifier.scopusid 2-s2.0-85216812138 -
dc.identifier.uri https://scholarworks.unist.ac.kr/handle/201301/86250 -
dc.identifier.wosid 001411918000001 -
dc.language 영어 -
dc.publisher WILEY-V C H VERLAG GMBH -
dc.title Nature Inspired Delivery Vehicles for CRISPR-Based Genome Editing -
dc.type Article -
dc.description.isOpenAccess TRUE -
dc.relation.journalWebOfScienceCategory Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter -
dc.relation.journalResearchArea Chemistry; Science & Technology - Other Topics; Materials Science; Physics -
dc.type.docType Review; Early Access -
dc.description.journalRegisteredClass scie -
dc.description.journalRegisteredClass scopus -
dc.subject.keywordAuthor delivery -
dc.subject.keywordAuthor genome editing -
dc.subject.keywordAuthor membrane vesicles -
dc.subject.keywordAuthor precision therapy -
dc.subject.keywordAuthor CRISPR -
dc.subject.keywordPlus ADENOASSOCIATED VIRUS VECTOR -
dc.subject.keywordPlus MEMBRANE-CAMOUFLAGED NANOPARTICLES -
dc.subject.keywordPlus IN-VIVO -
dc.subject.keywordPlus GENE-THERAPY -
dc.subject.keywordPlus EXTRACELLULAR VESICLES -
dc.subject.keywordPlus HIGHLY EFFICIENT -
dc.subject.keywordPlus INTRACELLULAR DELIVERY -
dc.subject.keywordPlus LIPID NANOPARTICLES -
dc.subject.keywordPlus AUREUS CRISPR-CAS9 -
dc.subject.keywordPlus IMMUNE-SYSTEM -

qrcode

Items in Repository are protected by copyright, with all rights reserved, unless otherwise indicated.